TT

Bernice L Z Oh1, Natasha Vinanica2, Desmond M H Wong2

  • 1Viva-University Children's Cancer Center, Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore.

Haematologica
|June 4, 2024
PubMed
概括

化学抗原受体 (CAR) T 细胞疗法对T 细胞急性淋巴细胞白血病 (T-ALL) 有前途. 挑战包括确定合适的点,避免CAR T细胞自我消灭,CD7作为潜在的点.